Neuropace, Inc. - Common Stock (NPCE)

NeuroPace (NASDAQ:NPCE) raised its 2026 revenue outlook after reporting first-quarter results that management said reflected continued demand for its RNS System and improving commercial execution across epilepsy treatment centers. The company reported total revenue of $22.1 million for the first qu

The company finished 2025 with a convincing pair of earnings beats.

NeuroPace (NPCE) Q4 2025 Earnings Call Transcript

NeuroPace (NPCE) Q3 2025 Earnings Call Transcript

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares plummeting a staggering 31.4%. The significant sell-off came despite the company reporting strong third-quarter 2025 earnings that largely met or exceeded

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.